These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 423142)

  • 1. Comparison of antineoplastic activity of aminoethylaminoanthraquinones and anthracycline antibiotics.
    Cheng CC; Zbinden G; Zee-Cheng RK
    J Pharm Sci; 1979 Mar; 68(3):393-6. PubMed ID: 423142
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative cardiac oxygen radical metabolism by anthracycline antibiotics, mitoxantrone, bisantrene, 4'-(9-acridinylamino)-methanesulfon-m-anisidide, and neocarzinostatin.
    Doroshow JH; Davies KJ
    Biochem Pharmacol; 1983 Oct; 32(19):2935-9. PubMed ID: 6313012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation.
    Bachur NR; Gordon SL; Gee MV
    Mol Pharmacol; 1977 Sep; 13(5):901-10. PubMed ID: 19695
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
    Zijlstra JG; Meijer C; Timmer-Bosscha H; Le TK; de Vries EG; Mulder NH
    Eur J Respir Dis Suppl; 1987; 149():53-5. PubMed ID: 3034649
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance.
    Hintzpeter J; Seliger JM; Hofman J; Martin HJ; Wsol V; Maser E
    Toxicol Appl Pharmacol; 2016 Feb; 293():21-9. PubMed ID: 26773812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anthracycline antitumor agents doxorubicin and daunorubicin reduce the activity of Candida albicans phospholipase B.
    Arai R; Sugita T; Nishikawa A
    Microbiol Immunol; 2004; 48(9):665-7. PubMed ID: 15383703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and activities of the BR96-doxorubicin immunoconjugate.
    Hellström I; Hellström KE; Senter PD
    Methods Mol Biol; 2001; 166():3-16. PubMed ID: 11217374
    [No Abstract]   [Full Text] [Related]  

  • 9. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.
    Gewirtz DA
    Biochem Pharmacol; 1999 Apr; 57(7):727-41. PubMed ID: 10075079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cross resistance in tumor cells and staphylococci with respect to anthracycline-group antineoplastic antibiotics].
    Shorin VA; Averbukh LA
    Antibiotiki; 1976 Oct; 21(10):914-9. PubMed ID: 999240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and experimental antitumor activity of a new semi-synthetic antibiotic: 14-diethoxyacetoxy daunorubicin (R.P. 33 921)].
    Maral R; Ducep JB; Farge D; Ponsinet G; Reisdorf D
    C R Acad Hebd Seances Acad Sci D; 1978 Feb; 286(5):443-6. PubMed ID: 418906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1996 Oct; 39(21):4135-8. PubMed ID: 8863788
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative cytotoxicity of adriamycin, mitoxantrone and bisantrene as measured by a human tumor cloning system.
    Cowan JD; Von Hoff DD; Clark GM
    Invest New Drugs; 1983; 1(2):139-44. PubMed ID: 6678863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anthracycline antibiotics on the reconstituted mitochondrial tricarboxylate carrier.
    Stipani I; Capalbo MI; Zara V
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1281-7. PubMed ID: 2590202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and clinical activity of a new anthracycline derivative: detorubicin (14-diethoxyacetoxydaunorubicin).
    Maral R; Heusse D; Lavelle F; Cueille G; Marlard M; Jacquillat C; Maral J; Auclerc MF; Weil M; Auclerc G; Bernard J
    Recent Results Cancer Res; 1980; 74():172-83. PubMed ID: 7444138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
    Povarov LS; Leont'eva OV; Bernaki PD; Olsuf'eva EN; Salimova EI; Pera P; Preobrazhenskaia MN
    Bioorg Khim; 1995 Dec; 21(12):925-32. PubMed ID: 8602889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of rat and human cardiac guanylate cyclase in vitro by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
    Levey GS; Levey BA; Ruiz E; Lehotay DC
    J Mol Cell Cardiol; 1979 Jun; 11(6):591-9. PubMed ID: 37344
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH; Kessel D
    Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of anthracycline-antibody complexes for specific antitumor activity.
    Pietersz GA; Smyth MJ; Farquhar I; McKenzie C
    Targeted Diagn Ther; 1988; 1():25-53. PubMed ID: 2979059
    [No Abstract]   [Full Text] [Related]  

  • 20. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.